Non-Cochrane · prognostic · PM42187628

Oral Manifestations in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Scocca Veronica, Sarnelli Giovanni, Pesce Marcella, et al. · Dentistry journal · 2026 · PubMed · doi:10.3390/dj14050250

Findings

15 findings

Population
Patients with inflammatory bowel disease (Crohn disease and ulcerative colitis)Inflammatory bowel disease (single-arm prevalence)None (single-arm)Oral ulcerations
Not specified · Not specified
Prevalence (proportion) 0.20 [0.11, 0.33]
GRADE not reported
13 studies · 2599 participants
Patients with inflammatory bowel disease (Crohn disease and ulcerative colitis)Inflammatory bowel disease (single-arm prevalence)None (single-arm)Taste changes
Not specified · Not specified
Prevalence (proportion) 0.16 [0.05, 0.32]
GRADE not reported
6 studies · 492 participants
Patients with inflammatory bowel disease (Crohn disease and ulcerative colitis)Inflammatory bowel disease (single-arm prevalence)None (single-arm)Dry mouth
Not specified · Not specified
Prevalence (proportion) 0.32 [0.14, 0.59]
GRADE not reported
8 studies · 2240 participants
Patients with inflammatory bowel disease (Crohn disease and ulcerative colitis)Inflammatory bowel disease (single-arm prevalence)None (single-arm)Tongue alterations (coated, geographic, fissured tongue)
Not specified · Not specified
Prevalence (proportion) 0.11 [0.04, 0.24]
GRADE not reported
5 studies · 248 participants
Patients with inflammatory bowel disease (Crohn disease and ulcerative colitis)Inflammatory bowel disease (single-arm prevalence)None (single-arm)Halitosis
Not specified · Not specified
Prevalence (proportion) 0.22 [0.07, 0.51]
GRADE not reported
9 studies · 3051 participants
Patients with inflammatory bowel disease (Crohn disease and ulcerative colitis)Inflammatory bowel disease (single-arm prevalence)None (single-arm)Stomatitis
Not specified · Not specified
Prevalence (proportion) 0.07 [0.01, 0.53]
GRADE not reported
5 studies · 2713 participants
Patients with inflammatory bowel disease (Crohn disease and ulcerative colitis)Inflammatory bowel disease (single-arm prevalence)None (single-arm)Oral aphthae
Not specified · Not specified
Prevalence (proportion) 0.07 [0.02, 0.23]
GRADE not reported
5 studies · 2070 participants
Patients with inflammatory bowel disease and healthy controlsInflammatory bowel disease (exposure)Healthy controlsBurning sensation
Not specified · Not specified
Burning sensation: no statistically significant difference between IBD patients and healthy controls (pooled p = 0.5498); OR and CI not reported
GRADE not reported
Studies not reported
Patients with inflammatory bowel disease and healthy controlsInflammatory bowel disease (exposure)Healthy controlsTaste changes
Not specified · Not specified
Taste changes: no statistically significant difference between IBD patients and healthy controls (pooled p = 0.618); OR and CI not reported
GRADE not reported
Studies not reported
Patients with inflammatory bowel disease and healthy controlsInflammatory bowel disease (exposure)Healthy controlsLip/gingival swelling
Not specified · Not specified
Lip/gingival swelling: no statistically significant difference between IBD patients and healthy controls (pooled p = 0.650); OR and CI not reported
GRADE not reported
Studies not reported
Patients with inflammatory bowel disease and healthy controlsInflammatory bowel disease (exposure)Healthy controlsAcidic taste
Not specified · Not specified
Acidic taste: no statistically significant difference between IBD patients and healthy controls (pooled p = 0.805); OR and CI not reported
GRADE not reported
Studies not reported
Patients with inflammatory bowel disease and healthy controlsInflammatory bowel disease (exposure)Healthy controlsOral ulcerations
Not specified · Not specified
Oral ulcerations: no statistically significant difference between IBD patients and healthy controls (pooled p = 0.338); OR and CI not reported
GRADE not reported
Studies not reported
Patients with inflammatory bowel disease and healthy controlsInflammatory bowel disease (exposure)Healthy controlsTongue alterations
Not specified · Not specified
Tongue alterations: no statistically significant difference between IBD patients and healthy controls (pooled p = 0.911); OR and CI not reported
GRADE not reported
Studies not reported
Patients with inflammatory bowel disease and healthy controlsInflammatory bowel disease (exposure)Healthy controlsHalitosis
Not specified · Not specified
Halitosis: no statistically significant difference between IBD patients and healthy controls (pooled p = 0.165); OR and CI not reported
GRADE not reported
Studies not reported
Patients with inflammatory bowel disease and healthy controlsInflammatory bowel disease (exposure)Healthy controlsDry mouth
Not specified · Not specified
Dry mouth: no statistically significant difference between IBD patients and healthy controls (pooled p = 0.157); OR and CI not reported
GRADE not reported
Studies not reported

Included primary studies 21

Open in Studies
StudyYearAlso included byOutcomes it informs hereTrial data
Szymanska 2014
Dental caries, prevalence and risk factors in patients with Crohn's disease.
PMID:24608416
20141 other reviewOral ulcerations; Dry mouth; Halitosisnot extracted yet
Brito 2008
Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis.
PMID:18400026
2008this review onlyOral ulcerations; Oral aphthaenot extracted yet
Cagir 2024
Specific Oral Manifestations in Adults with Crohn's Disease.
PMID:38999519
2024this review onlynot statednot extracted yet
Elahi 2012
Association of oral manifestations with ulcerative colitis.
PMID:24834217
2012this review onlyOral ulcerations; Dry mouth; Halitosis; Tongue alterations (coated, geographic, fissured tongue); Taste changesnot extracted yet
Greuter 2017
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment.
PMID:27801751
2017this review onlyOral aphthae; Stomatitisnot extracted yet
Grossner-Schreiber 2006
Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study.
PMID:16820035
2006this review onlynot statednot extracted yet
Habashneh 2012
The association between inflammatory bowel disease and periodontitis among Jordanians: a case-control study.
PMID:22050539
2012this review onlynot statednot extracted yet
Harty 2005
A prospective study of the oral manifestations of Crohn's disease.
PMID:16234026
2005this review onlyOral ulcerations; Stomatitisnot extracted yet
Hu 2022
Oral Microbiome of Crohn's Disease Patients With and Without Oral Manifestations.
PMID:35511486
2022this review onlyOral ulcerationsnot extracted yet
Jose 2009
Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease.
PMID:18626963
2009this review onlyOral aphthae; Stomatitisnot extracted yet
Katz 2003
Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease.
PMID:12617256
2003this review onlyOral ulcerations; Dry mouth; Halitosis; Tongue alterations (coated, geographic, fissured tongue); Taste changesnot extracted yet
Khouri 2004
Is orofacial granulomatosis in children a feature of Crohn's disease?
PMID:16092468
2005this review onlynot statednot extracted yet
Khozeimeh 2020
Oral manifestations in inflammatory bowel disease: A cross-sectional study in Isfahan.
PMID:34084291
2021this review onlyOral ulcerations; Dry mouth; Halitosis; Taste changesnot extracted yet
Koutsochristou 2015
Dental Caries and Periodontal Disease in Children and Adolescents with Inflammatory Bowel Disease: A Case-Control Study.
PMID:25985243
2015this review onlyOral aphthaenot extracted yet
Laranjeira 2015
Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients.
PMID:26039827
2015this review onlyOral ulcerations; Dry mouth; Halitosis; Taste changesnot extracted yet
Mohan Kumar 2016
Association of oral manifestations in ulcerative colitis: A pilot study.
PMID:30158772
2018this review onlyOral ulcerations; Dry mouth; Halitosis; Tongue alterations (coated, geographic, fissured tongue); Stomatitis; Taste changesnot extracted yet
Oviedo 2017
Frequency of Oral Manifestation in Patients with Inflammatory Bowel Disease in Chile
DOI:10.4067/s0718-381x2017000300267
2017this review onlyOral ulcerations; Oral aphthaenot extracted yet
Rikardsson 2009
Perceived oral health in patients with Crohn's disease.
PMID:19780435
2009this review onlyOral ulcerations; Dry mouth; Halitosisnot extracted yet
Tabarsi 2024
Association of oral manifestations with severity of the disease in ulcerative colitis patients.
PMID:39448908
2024this review onlyOral ulcerations; Dry mouth; Halitosis; Tongue alterations (coated, geographic, fissured tongue); Taste changesnot extracted yet
Zervou 2004
matched by author and year (probable)
NRthis review onlyOral ulcerations; Tongue alterations (coated, geographic, fissured tongue)not extracted yet
Zippi 2014
Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.
PMID:25516659
2014this review onlyHalitosis; Stomatitisnot extracted yet

Overlap with other reviews

Reviews that include the same primary studies are not independent evidence. Shared counts match studies by PMID, DOI or NCT, and otherwise by author and year (a probable match). Only the non-Cochrane dental reviews have study lists, so overlap with Cochrane reviews is not counted yet.

Review question

ElementPlanned (methods)Found (results)
PopulationPatients with a diagnosis of inflammatory bowel diseasePatients with IBD, 5914 patients and 1877 healthy controls (n=21)
InterventionUlcerative colitis and Crohn's diseaseCrohn's disease (70%) and ulcerative colitis (30%) (n=21)
ComparisonIBD versus healthy controlsHealthy controls (n=12 case-control studies)
OutcomesOral signs and symptomsOral ulcerations (n=13), dry mouth (n=8), halitosis (n=9), tongue alterations (n=5), oral aphthae (n=5), stomatitis (n=5), taste changes (n=6); periodontal manifestations narrative (n=7)
Study designsRetrospective and prospective cohort studies, case-control and cross-sectional studies, randomized clinical trials12 case-control studies, remainder cohort and cross-sectional (n=21)
TimingNoneNot specified